Polar Capital Holdings Plc

Position in JNJ — Johnson & Johnson

CIK 1837309 London, X0

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$199,009,622

+$191,447,982 QoQ

Shares Held

783,595

+1539.3% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.57%

of 13F equity value

Holder Rank

#201

of 4,647 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Polar Capital Holdings Plc holds $871,476,071 across 4 Drug Manufacturers - General names. JNJ ranks #3 (22.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	251,997	$302,252,786
2	AZN	Astrazeneca PLC	1,247,549	$236,560,241
3	JNJ	Johnson & Johnson This page	783,595	$199,009,622
4	AMGN	Amgen Inc	369,086	$133,653,422

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$199,009,622	783,595	+1539.3%	Shares	Defined	2026-08-14
2024-03-31	$7,561,640	47,801	-5.8%	Shares	Defined	2024-05-15
2023-12-31	$7,951,420	50,730	-86.3%	Shares	Defined	2024-02-14
2023-09-30	$57,730,606	370,662	-19.0%	Shares	Defined	2023-11-22
2023-06-30	$75,752,214	457,662	+13.3%	Shares	Defined	2023-12-13
2023-03-31	$62,599,075	403,865	+11.8%	Shares	Defined	2023-12-13
2022-12-31	$63,803,506	361,186	+11.2%	Shares	Defined	2023-02-14
2022-09-30	$53,059,981	324,804	+11.8%	Shares	Defined	2022-11-14
2022-06-30	$51,579,968	290,575	-3.5%	Shares	Defined	2022-08-15
2022-03-31	$53,341,799	300,975	+2.2%	Shares	Defined	2022-05-16
2021-12-31	$50,392,945	294,575	-61.6%	Shares	Defined	2022-02-14
2021-09-30	$124,047,827	768,098	-35.6%	Shares	Defined	2021-11-15
2021-06-30	$196,538,609	1,193,023	+20.0%	Shares	Defined	2021-08-16
2021-03-31	$163,449,855	994,523	-8.4%	Shares	Sole	2021-05-17
2020-12-31	$170,781,851	1,085,156	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.